Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorien M Schrijvers

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Biotechnology Letters|August 2, 2003
Nucleofection as an efficient nonviral transfection method for human monocytic cellsWim Martinet, Dorien M Schrijvers, Mark M Kockx
British Journal of Pharmacology|March 23, 2011
Pharmacological modulation of cell death in atherosclerosis: a promising approach towards plaque stabilization?Wim Martinet, Dorien M Schrijvers, Guido R Y De Meyer
Arteriosclerosis, Thrombosis, and Vascular Biology|November 19, 2011
Autophagy in atherosclerosis: a potential drug target for plaque stabilizationDorien M Schrijvers, Guido R Y De Meyer, Wim Martinet
Basic Research in Cardiology|September 13, 2012
Molecular and cellular mechanisms of macrophage survival in atherosclerosisWim Martinet, Dorien M Schrijvers, Guido R Y De Meyer
Basic Research in Cardiology|May 26, 2011
Necrotic cell death in atherosclerosisWim Martinet, Dorien M Schrijvers, Guido R Y De Meyer
Arteriosclerosis, Thrombosis, and Vascular Biology|May 3, 2008
Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- miceEdward Thorp, Dongying Cui, Dorien M Schrijvers, et al.
Current Pharmaceutical Design|February 27, 2013
Potential use of dendritic cells for anti-atherosclerotic therapyIlse Van Brussel, Dorien M Schrijvers, Emily A Van Vré, et al.
Cardiovascular Research|November 7, 2006
Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stabilityDorien M Schrijvers, Guido R Y De Meyer, Arnold G Herman, et al.
Autophagy|July 29, 2006
z-VAD-fmk-induced non-apoptotic cell death of macrophages: possibilities and limitations for atherosclerotic plaque stabilizationWim Martinet, Dorien M Schrijvers, Arnold G Herman, et al.
Vascular Pharmacology|January 31, 2016
Cholesterol-independent effects of atorvastatin prevent cardiovascular morbidity and mortality in a mouse model of atherosclerotic plaque ruptureLynn Roth, Miche Rombouts, Dorien M Schrijvers, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Biotechnology Letters|August 2, 2003
Nucleofection as an efficient nonviral transfection method for human monocytic cellsWim Martinet, Dorien M Schrijvers, Mark M Kockx
British Journal of Pharmacology|March 23, 2011
Pharmacological modulation of cell death in atherosclerosis: a promising approach towards plaque stabilization?Wim Martinet, Dorien M Schrijvers, Guido R Y De Meyer
Arteriosclerosis, Thrombosis, and Vascular Biology|November 19, 2011
Autophagy in atherosclerosis: a potential drug target for plaque stabilizationDorien M Schrijvers, Guido R Y De Meyer, Wim Martinet
Basic Research in Cardiology|September 13, 2012
Molecular and cellular mechanisms of macrophage survival in atherosclerosisWim Martinet, Dorien M Schrijvers, Guido R Y De Meyer
Basic Research in Cardiology|May 26, 2011
Necrotic cell death in atherosclerosisWim Martinet, Dorien M Schrijvers, Guido R Y De Meyer
Arteriosclerosis, Thrombosis, and Vascular Biology|May 3, 2008
Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- miceEdward Thorp, Dongying Cui, Dorien M Schrijvers, et al.
Current Pharmaceutical Design|February 27, 2013
Potential use of dendritic cells for anti-atherosclerotic therapyIlse Van Brussel, Dorien M Schrijvers, Emily A Van Vré, et al.
Cardiovascular Research|November 7, 2006
Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stabilityDorien M Schrijvers, Guido R Y De Meyer, Arnold G Herman, et al.
Autophagy|July 29, 2006
z-VAD-fmk-induced non-apoptotic cell death of macrophages: possibilities and limitations for atherosclerotic plaque stabilizationWim Martinet, Dorien M Schrijvers, Arnold G Herman, et al.
Vascular Pharmacology|January 31, 2016
Cholesterol-independent effects of atorvastatin prevent cardiovascular morbidity and mortality in a mouse model of atherosclerotic plaque ruptureLynn Roth, Miche Rombouts, Dorien M Schrijvers, et al.
Pageof 6